FDA Approves Xalkori with Companion Diagnostic for a Type of Late-stage Lung Cancer
FDA Approves Xalkori with Companion Diagnostic for a Type of Late-stage Lung Cancer PR Newswire SILVER SPRING, Md., Aug. 26, 2011 Second targeted therapy approved with a test this year SILVER SPRING, Md. , Aug. […]